Literature DB >> 10456903

Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

T F Murphy1, C Kirkham, E DeNardin, S Sethi.   

Abstract

Moraxella catarrhalis is an important cause of otitis media in children and lower respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). Outer membrane protein CD (OMP CD) is a 45-kDa protein which is a potential vaccine antigen to prevent infections caused by M. catarrhalis. Eight monoclonal antibodies were used to study the antigenic structure of the OMP CD molecule by assaying recombinant peptides corresponding to the sequence of the protein. This approach identified two surface-exposed epitopes, including one near the amino terminus (amino acids 25 to 44) and one in the central region of the molecule (amino acids 261 to 331). Assays with serum and sputum supernatants of adults with COPD revealed variable levels of antibodies to OMP CD among individuals. To determine which portions of the OMP CD molecule were recognized by human antibodies, three human serum samples were studied with six recombinant peptides which span the sequence of OMP CD. All three sera contained immunoglobulin G antibodies which recognized exclusively the peptide corresponding to amino acids 203 to 260 by immunoblot assay. Adsorption experiments with whole bacteria established that some of the human antibodies are directed at surface-exposed epitopes on OMP CD. We conclude that OMP CD is a highly conserved molecule which contains at least two separate epitopes which are exposed on the bacterial surface. While individual adults with COPD show variability in the immune response to OMP CD, a specific region of the OMP CD molecule (amino acids 203 to 260) is important as a target of the human immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456903      PMCID: PMC96781     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Bacterial infection in chronic obstructive pulmonary disease.

Authors:  T F Murphy; S Sethi
Journal:  Am Rev Respir Dis       Date:  1992-10

2.  Cell fusion.

Authors:  R H Kennett
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Nonencapsulated Haemophilus influenzae in Aboriginal infants with otitis media: prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer.

Authors:  H C Smith-Vaughan; K S Sriprakash; J D Mathews; D J Kemp
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Authors:  K Groeneveld; L van Alphen; C Voorter; P P Eijk; H M Jansen; H C Zanen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.

Authors:  A Verghese; D Roberson; J H Kalbfleisch; F Sarubbi
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum.

Authors:  K Groeneveld; P P Eijk; L van Alphen; H M Jansen; H C Zanen
Journal:  Am Rev Respir Dis       Date:  1990-05

10.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more
  21 in total

1.  Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Authors:  Katie J Edwards; Johanna M Schwingel; Anup K Datta; Anthony A Campagnari
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells.

Authors:  Brian Bullard; Serena L Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level.

Authors:  E R Lafontaine; N J Wagner; E J Hansen
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

5.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

Review 6.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 7.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

8.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 10.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.